Inventor · disambiguated record
Katie Lynn Mccarty
Also filed as: MCCARTY KATIE · MCCARTY KATIE L · MCCARTY KATIE LYNN
5 granted patents·2 pending applications·76 citations·filing 2015–2024
82Inventor score
Files withVERTEX PHARMA7
Top patents by PatentIndex Score
7 records- 0194US11155533B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Oct 26, 2021·10 cites·13 claims
- 0294US10980746B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2018·Granted Apr 20, 2021·13 cites·25 claims
- 0393US10654829B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2018·Granted May 19, 2020·21 cites·23 claims
- 0493US10206877B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2015·Granted Feb 19, 2019·29 cites·27 claims
- 0592US11951212B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2021·Granted Apr 9, 2024·3 cites·37 claims
- 0662US2025186419A1Dosing regimens for treating painVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0745US2024285596A1Solid dosage forms and dosing regimens comprising (2r,3s,4s,5r)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katie Lynn Mccarty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →